108 related articles for article (PubMed ID: 1447752)
1. Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin.
Macor JE; Blake J; Fox CB; Johnson C; Koe BK; Lebel LA; Morrone JM; Ryan K; Schmidt AW; Schulz DW
J Med Chem; 1992 Nov; 35(23):4503-5. PubMed ID: 1447752
[No Abstract] [Full Text] [Related]
2. A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties.
Laban U; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE
Bioorg Med Chem Lett; 2001 Mar; 11(6):793-5. PubMed ID: 11277522
[TBL] [Abstract][Full Text] [Related]
3. 5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity.
Macor JE; Blank DH; Fox CB; Lebel LA; Newman ME; Post RJ; Ryan K; Schmidt AW; Schulz DW; Koe BK
J Med Chem; 1994 Aug; 37(16):2509-12. PubMed ID: 8057297
[No Abstract] [Full Text] [Related]
4. 1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors.
Macor JE; Fox CB; Johnson C; Koe BK; Lebel LA; Zorn SH
J Med Chem; 1992 Oct; 35(20):3625-32. PubMed ID: 1433172
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.
Cole DC; Lennox WJ; Lombardi S; Ellingboe JW; Bernotas RC; Tawa GJ; Mazandarani H; Smith DL; Zhang G; Coupet J; Schechter LE
J Med Chem; 2005 Jan; 48(2):353-6. PubMed ID: 15658848
[TBL] [Abstract][Full Text] [Related]
6. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
[TBL] [Abstract][Full Text] [Related]
7. N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarboxamides as selective 5-HT1A receptor agonists.
Fujio M; Togo Y; Tomozane H; Kuroita T; Morio Y; Katayama J; Matsumoto Y
Bioorg Med Chem Lett; 2000 Mar; 10(5):509-12. PubMed ID: 10743959
[TBL] [Abstract][Full Text] [Related]
8. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Mattsson C; Svensson P; Boettcher H; Sonesson C
Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
[TBL] [Abstract][Full Text] [Related]
10. N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.
Xu YC; Johnson KW; Phebus LA; Cohen M; Nelson DL; Schenck K; Walker CD; Fritz JE; Kaldor SW; LeTourneau ME; Murff RE; Zgombick JM; Calligaro DO; Audia JE; Schaus JM
J Med Chem; 2001 Nov; 44(24):4031-4. PubMed ID: 11708905
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
[TBL] [Abstract][Full Text] [Related]
12. Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.
Gerasimov M; Marona-Lewicka D; Kurrasch-Orbaugh DM; Qandil AM; Nichols DE
J Med Chem; 1999 Oct; 42(20):4257-63. PubMed ID: 10514296
[TBL] [Abstract][Full Text] [Related]
13. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 3-[2-(dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin- 2-yl)-methyl]-1H-indole and analogues: agonists for the 5-HT1D receptor.
Castro JL; Baker R; Guiblin AR; Hobbs SC; Jenkins MR; Russell MG; Beer MS; Stanton JA; Scholey K; Hargreaves RJ
J Med Chem; 1994 Sep; 37(19):3023-32. PubMed ID: 7932524
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation.
Jandu KS; Barrett V; Brockwell M; Cambridge D; Farrant DR; Foster C; Giles H; Glen RC; Hill AP; Hobbs H; Honey A; Martin GR; Salmon J; Smith D; Woollard P; Selwood DL
J Med Chem; 2001 Mar; 44(5):681-93. PubMed ID: 11262079
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists.
Kakigami T; Usui T; Tsukamoto K; Kataoka T
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):42-52. PubMed ID: 9468636
[TBL] [Abstract][Full Text] [Related]
17. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF
J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922
[TBL] [Abstract][Full Text] [Related]
19. Serotonin 5-HT4 receptor agonistic activity of the optical isomers of (+/-)-4-amino-N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-5-chloro-2,3- dihydro-2-methylbenzo[b]furan-7-carboxamide.
Kakigami T; Usui T; Ikami T; Tsukamoto K; Miwa Y; Taga T; Kataoka T
Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):1039-43. PubMed ID: 9658578
[TBL] [Abstract][Full Text] [Related]
20. 5-HT4 receptor ligands: applications and new prospects.
Langlois M; Fischmeister R
J Med Chem; 2003 Jan; 46(3):319-44. PubMed ID: 12540230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
